There are 15 co-research centers jointly built by the College and well-known pharmaceutical companies, which have been rewarded with one piece of the National First-Class New Drug Certificate and 11 pieces of the National Second-Class New Drug Certificates and have had 4 guiding principles and 3 strains of drugs they had co-developed included into the Chinese Pharmacopoeia. The College has successfully applied 2 pieces of the 1.1-type new drug clinical approvals by itself and 4 pieces of the 1.1-type chemical drug clinical approvals together with some pharmaceutical enterprises. By transforming its patents into practical application, the College has developed multiple advanced intelligent pharmaceutical technologies to instruct nearly 100 large-scale production lines with an annual drug output value of RMB 30 billion and therefore has greatly helped these pharmaceutical enterprise finish its transformation and upgrading and yield substantial outcomes, which has been reported by CCTV repeatedly.

1. Modernization of TCM Industry Technology Innovation Strategic Alliance in Zhejiang Province

2. ZJU–NanFang Medical R&D Center of the Preparation of Transdermal Drug Delivery System

3. ZJU–Dongting Pharma R&D Base of Drugs for Nervous-mental System Diseases

4. ZJU–JUMPCAN Pharmaceutical Preparation Research Center of Targeted Drugs

5. ZJU–Chiatai Qingchunbao Process Control Technology Research Center of TCM Production Quality

6. ZJU–CONBA TCM Research Center of “Zhebawei” Chinese Crude Drugs

7. ZJU–TASLY Joint Laboratory of Computer-aided Pharmaceutical Analysis

8. ZJU–Wang Changgen Research Center of Modern Chinese Medicine

9. ZJU–Yongtai R&D Laboratory

10. ZJU–Yongning Pharma R&D Center of New Drugs